Genotype . | n . | Normal (%) . | PFO (%) . | ASA (%) . | PFO + ASA (%) . | ASD (%) . |
---|---|---|---|---|---|---|
Wild type | 21 | 18 (85.7) | 3 (14.3) | 0 (0) | 0 (0) | 0 (0) |
Tbx20lacZ/+ | 20 | 9 (45) | 6 (30) | 1 (5) | 4 (20) | 0 (0) |
Nkx2-5GFP/+ | 24 | 2 (8.3) | 12 (50) | 1 (4.2) | 9 (37.5) | 0 (0) |
Tbx20lacZ/+/Nkx2-5GFP/+ | 24 | 3 (12.5) | 4 (16.6) | 1 (4.2) | 12 (50)* | 4 (16.7)† |
Genotype . | n . | Normal (%) . | PFO (%) . | ASA (%) . | PFO + ASA (%) . | ASD (%) . |
---|---|---|---|---|---|---|
Wild type | 21 | 18 (85.7) | 3 (14.3) | 0 (0) | 0 (0) | 0 (0) |
Tbx20lacZ/+ | 20 | 9 (45) | 6 (30) | 1 (5) | 4 (20) | 0 (0) |
Nkx2-5GFP/+ | 24 | 2 (8.3) | 12 (50) | 1 (4.2) | 9 (37.5) | 0 (0) |
Tbx20lacZ/+/Nkx2-5GFP/+ | 24 | 3 (12.5) | 4 (16.6) | 1 (4.2) | 12 (50)* | 4 (16.7)† |